Research & Development
13 November 2018 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has presented new data from the company's clinical development programme for advanced fibrosis due to ...
13 November 2018 - - US-based RNAi therapeutics company Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), the leading, announced TODAY that the company presented updated results from the ongoing Phas...
13 November 2018 - - US-based immunotherapy company Alpine Immune Sciences, Inc. (NASDAQ: ALPN) has advanced its oncology programme, the company said.

Following promising preclinical data...
13 November 2018 - - US-based biotechnology company Obsidian Therapeutics, Inc has presented preclinical data demonstrating fine-tuned regulation of cytokine production and CAR-T function using Destab...
13 November 2018 - - Swiss specialty biopharmaceutical group Ferring Pharmaceuticals Inc. has launched Nocdurna (desmopressin acetate), the first and only sublingual tablet approved in the United...
13 November 2018 - - US-based biopharmaceutical company Omeros Corp. (NASDAQ: OMER) has priced an offering of USD 210m aggregate principal amount of its 6.25% convertible senior notes due 2023 in a pr...
Related Headlines